Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
NewAmsterdam Pharma Company N.V. - Ordinary Shares
(NQ:
NAMS
)
20.80
-0.04 (-0.19%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about NewAmsterdam Pharma Company N.V. - Ordinary Shares
< Previous
1
2
Next >
NewAmsterdam Dives — And Sacrifices A Cup Base — Despite A Winning Cholesterol Study
November 20, 2024
The company's combination treatment lowered LDL cholesterol by about 50% over 84 days.
Via
Investor's Business Daily
NewAmsterdam Pharma Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
November 11, 2024
Via
Benzinga
What 4 Analyst Ratings Have To Say About NewAmsterdam Pharma
November 07, 2024
Via
Benzinga
Expert Ratings For NewAmsterdam Pharma
September 23, 2024
Via
Benzinga
NewAmsterdam Pharma's Cholesterol Drug To See Blockbuster Sales, Bullish Analyst Sees Massive Upside
August 28, 2024
Needham initiates coverage on NewAmsterdam Pharma with a Buy rating, highlighting the potential of its cholesterol-lowering drug, obicetrapib.
Via
Benzinga
Analyst Confident In NewAmsterdam Pharma's Cholesterol Drug Despite Mixed Reactions To Study Results
July 30, 2024
NewAmsterdam Pharma announced positive topline results from the Phase 3 BROOKLYN trial for obicetrapib, showing a significant LDL-C reduction in HeFH patients. The stock fell 8.35% despite the success,...
Via
Benzinga
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 29, 2024
Via
Benzinga
NewAmsterdam Touts Cholesterol Drug Success, But Results Trail Analysts' Expectations
July 29, 2024
The company is hoping to use a new mechanism to lower "bad" LDL cholesterol.
Via
Investor's Business Daily
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
July 05, 2024
A number of companies are working on new drugs for high lipids, including cholesterol and triglycerides.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's After-Market Session
April 29, 2024
Via
Benzinga
World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday
January 19, 2024
U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of World Acceptance Corporation (NASDAQ: WRLD) rose sharply during Friday’s session following upbeat...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 19, 2024
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode...
Via
Benzinga
Cholesterol Player NewAmsterdam Pharma's Obicetrapib Is A Potential Blockbuster In Cardiovascular Market: Bullish Analyst Says
January 16, 2024
Piper Sandler's coverage on NewAmsterdam Pharma and its clinical-stage therapy, Obicetrapib, a potent CETP inhibitor targeting cardiovascular health. With a unique mechanism, superior efficacy, and...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 10, 2024
Via
Benzinga
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 10, 2024
Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 31, 2023
Via
Benzinga
Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 23, 2023
Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.
Via
Benzinga
FMC, Li-Cycle Holdings, Okta And Other Big Stocks Moving Lower On Monday
October 23, 2023
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Shares of NewAmsterdam Pharma Were Plummeting on Wednesday
June 07, 2023
The company announced a stock sale to help fund operations.
Via
The Motley Fool
Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 07, 2023
Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 07, 2023
Via
Benzinga
Stocks Open Higher; US Trade Deficit Widens In April
June 07, 2023
U.S. stocks traded mostly higher this morning, with Nasdaq Composite gaining over 75 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.05% to 33,590.92 while the NASDAQ...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 07, 2023
Via
Benzinga
3 Drug Stocks to Watch as Alzheimer’s Clinical Trials End
February 24, 2023
These drug companies are running clinical trials for Alzheimer's drugs. The cure is worth billions, so these are the drug stocks to watch.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 31, 2023
Via
Benzinga
US Stocks Mixed; McDonald's Earnings Top Estimates
January 31, 2023
U.S. stocks traded mixed this morning, with the Dow Jones dropping around 30 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.09% to 33,685.72 while the NASDAQ rose 0.29%...
Via
Benzinga
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 25, 2023
Gainers
Via
Benzinga
Why Applied UV Shares Are Trading Higher By 46%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 27, 2023
Gainers FOXO Technologies Inc. (NYSE: FOXO) shares jumped 109% to $1.07. Akanda Corp. (NASDAQ: AKAN) rose 59% to $0.4459 after jumping 47% on Thursday.
Via
Benzinga
Why AppTech Payments Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 31, 2023
Gainers
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.